Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 408

1.

Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions.

SPRINT MIND Investigators for the SPRINT Research Group, Nasrallah IM, Pajewski NM, Auchus AP, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Doshi J, Erus G, Fine LJ, Gaussoin SA, Harris D, Johnson KC, Kimmel PL, Kurella Tamura M, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT Jr, Wright CB, Williamson JD, Bryan RN.

JAMA. 2019 Aug 13;322(6):524-534. doi: 10.1001/jama.2019.10551.

PMID:
31408137
2.

Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.

Beddhu S, Shen J, Cheung AK, Kimmel PL, Chertow GM, Wei G, Boucher RE, Chonchol M, Arman F, Campbell RC, Contreras G, Dwyer JP, Freedman BI, Ix JH, Kirchner K, Papademetriou V, Pisoni R, Rocco MV, Whelton PK, Greene T.

J Am Soc Nephrol. 2019 Aug;30(8):1523-1533. doi: 10.1681/ASN.2018121261. Epub 2019 Jul 19.

PMID:
31324734
3.

Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT.

Ghazi L, Pajewski NM, Rifkin DE, Bates JT, Chang TI, Cushman WC, Glasser SP, Haley WE, Johnson KC, Kostis WJ, Papademetriou V, Rahman M, Simmons DL, Taylor A, Whelton PK, Wright JT, Bhatt UY, Drawz PE.

J Am Heart Assoc. 2019 Jul 16;8(14):e011706. doi: 10.1161/JAHA.118.011706. Epub 2019 Jul 15.

4.

Influence of prediabetes on the effects of intensive systolic blood pressure control on kidney events.

Rathi N, Whelton PK, Chertow GM, Cushman WC, Cheung AK, Wei G, Boucher R, Kimmel PL, Bress A, Kramer HJ, Al-Marji C, Greene T, Beddhu S.

Am J Hypertens. 2019 Jun 29. pii: hpz105. doi: 10.1093/ajh/hpz105. [Epub ahead of print]

PMID:
31257407
5.

Joint modeling of systolic blood pressure and the primary outcome in Systolic Blood Pressure Intervention Trial.

Reboussin DM, Whelton PK.

J Hypertens. 2019 Aug;37(8):1729. doi: 10.1097/HJH.0000000000002179. No abstract available.

PMID:
31246770
6.

Proportion of US Adults Recommended Out-of-Clinic Blood Pressure Monitoring According to the 2017 Hypertension Clinical Practice Guidelines.

Booth JN 3rd, Hubbard D, Sakhuja S, Yano Y, Whelton PK, Wright JT Jr, Shimbo D, Muntner P.

Hypertension. 2019 Aug;74(2):399-406. doi: 10.1161/HYPERTENSIONAHA.119.12775. Epub 2019 Jun 24.

PMID:
31230550
7.

Frequency and Prognosis of Treated Hypertensive Patients According to Prior and New Blood Pressure Goals.

Ruilope LM, Ruiz-Hurtado G, Barderas MG, de la Cruz JJ, Lucia A, de la Sierra A, Gorostidi M, Vinyoles E, Segura J, Solís J, Arribas F, García-Puig J, Tamargo J, O'Brien E, Volpe M, Whelton PK, Williams B, Banegas JR.

Hypertension. 2019 Jul;74(1):130-136. doi: 10.1161/HYPERTENSIONAHA.119.12921. Epub 2019 May 28.

PMID:
31132953
8.

Evolution of Blood Pressure Clinical Practice Guidelines: A Personal Perspective.

Whelton PK.

Can J Cardiol. 2019 May;35(5):570-581. doi: 10.1016/j.cjca.2019.02.019. Epub 2019 Feb 27. Review.

PMID:
31030860
9.

Aligning Adult and Pediatric Blood Pressure Guidelines.

Gidding SS, Whelton PK, Carey RM, Flynn J, Kaelber DC, Baker-Smith C.

Hypertension. 2019 May;73(5):938-943. doi: 10.1161/HYPERTENSIONAHA.119.12653. No abstract available.

PMID:
30929515
10.

Evidence Supporting the Blood Pressure Treatment Goal of Less Than 130/80 mm Hg.

Reboussin DM, Carey RM, Whelton PK.

Hypertension. 2019 May;73(5):972-974. doi: 10.1161/HYPERTENSIONAHA.119.12804. No abstract available.

PMID:
30879361
11.

Cardiovascular Disease Risk Estimation in China.

Whelton PK, Colantonio LD.

Ann Intern Med. 2019 Mar 5;170(5):340-341. doi: 10.7326/M18-3301. Epub 2019 Feb 19. No abstract available.

12.

Rate of change in body mass index at different ages during childhood and adult obesity risk.

Zhang T, Whelton PK, Xi B, Krousel-Wood M, Bazzano L, He J, Chen W, Li S.

Pediatr Obes. 2019 Jul;14(7):e12513. doi: 10.1111/ijpo.12513. Epub 2019 Jan 31.

PMID:
30702812
13.

Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.

SPRINT MIND Investigators for the SPRINT Research Group, Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Erus G, Fine LJ, Gaussoin SA, Harris D, Hsieh MK, Johnson KC, Kimmel PL, Tamura MK, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nasrallah IM, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT Jr, Wright CB.

JAMA. 2019 Feb 12;321(6):553-561. doi: 10.1001/jama.2018.21442.

14.

Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel.

Muntner P, Einhorn PT, Cushman WC, Whelton PK, Bello NA, Drawz PE, Green BB, Jones DW, Juraschek SP, Margolis KL, Miller ER 3rd, Navar AM, Ostchega Y, Rakotz MK, Rosner B, Schwartz JE, Shimbo D, Stergiou GS, Townsend RR, Williamson JD, Wright JT Jr, Appel LJ; 2017 National Heart, Lung, and Blood Institute Working Group.

J Am Coll Cardiol. 2019 Jan 29;73(3):317-335. doi: 10.1016/j.jacc.2018.10.069. Review.

PMID:
30678763
15.

Cardiovascular Disease and Mortality in Adults Aged ≥60 Years According to Recommendations by the American College of Cardiology/American Heart Association and American College of Physicians/American Academy of Family Physicians.

Jaeger BC, Anstey DE, Bress AP, Booth JN 3rd, Butler M, Clark D 3rd, Howard G, Kalinowski J, Long DL, Ogedegbe G, Plante TB, Shimbo D, Sims M, Supiano MA, Whelton PK, Muntner P.

Hypertension. 2019 Feb;73(2):327-334. doi: 10.1161/HYPERTENSIONAHA.118.12291.

PMID:
30595115
16.

Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.

Bress AP, Colantonio LD, Cooper RS, Kramer H, Booth JN 3rd, Odden MC, Bibbins-Domingo K, Shimbo D, Whelton PK, Levitan EB, Howard G, Bellows BK, Kleindorfer D, Safford MM, Muntner P, Moran AE.

Circulation. 2019 Jan 2;139(1):24-36. doi: 10.1161/CIRCULATIONAHA.118.035640.

PMID:
30586736
17.

Prevalence of Apparent Treatment-Resistant Hypertension in the United States.

Carey RM, Sakhuja S, Calhoun DA, Whelton PK, Muntner P.

Hypertension. 2019 Feb;73(2):424-431. doi: 10.1161/HYPERTENSIONAHA.118.12191.

PMID:
30580690
18.

Rationale for Ambulatory and Home Blood Pressure Monitoring Thresholds in the 2017 American College of Cardiology/American Heart Association Guideline.

Muntner P, Carey RM, Jamerson K, Wright JT Jr, Whelton PK.

Hypertension. 2019 Jan;73(1):33-38. doi: 10.1161/HYPERTENSIONAHA.118.11946. No abstract available.

PMID:
30571569
19.

Reprint of: Prevention and Control of Hypertension: JACC Health Promotion Series.

Carey RM, Muntner P, Bosworth HB, Whelton PK.

J Am Coll Cardiol. 2018 Dec 11;72(23 Pt B):2996-3011. doi: 10.1016/j.jacc.2018.10.022. Review.

PMID:
30522633
20.

Supplemental Content

Loading ...
Support Center